VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT05156125 · TERMINATED
Trial details
- NCT number
- NCT05156125
- Sponsor
- Oppilan Pharma Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2023-08-30
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.